Mark E. Zupec

663 citations

18 papers · 546 indexed · h-index 15

Impact in

Molecular Biology
- Chemical Synthesis and Analysis
- Protein Kinase Regulation and GTPase Signaling
- Glycosylation and Glycoproteins Research
Immunology and Allergy

Papers in ⓘ

Immunology and Allergy 2
- Cell Adhesion Molecules Research 2
Hematology 3
- Platelet Disorders and Treatments 3

Co-authors: James A. Sikorski (7 shared papers)Daniel P. Getman (7 shared papers)Balekudru Devadas (7 shared papers)Sandra K. Freeman (7 shared papers)Charles A. McWherter (7 shared papers)Jeffrey I. Gordon (6 shared papers)Srinivasan Nagarajan (5 shared papers)David Brown (5 shared papers)
Journals: Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)Growth Factors (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

Mark E. Zupec

18 papers receiving 504 citations

Peers

Countries citing papers authored by Mark E. Zupec

Since Specialization

Citations

This map shows the geographic impact of Mark E. Zupec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Zupec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Zupec more than expected).

Fields of papers citing papers by Mark E. Zupec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Zupec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Zupec. The network helps show where Mark E. Zupec may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Zupec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Zupec Line = papers co-authored together Mark E. Zupec links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Design and Synthesis of Novel Imidazole-Substituted Dipeptide Amides as Potent and Selective Inhibitors of Candida albicans MyristoylCoA:Protein N-Myristoyltransferase and Identification of Related Tripeptide Inhibitors with Mechanism-Based Antifungal Activity Journal of Medicinal Chemistry ·Balekudru Devadas, Sandra K. Freeman, Mark E. Zupec, Hwang-Fun Lu, Srinivasan Nagarajan, Nandini S. Kishore, Jennifer K. Lodge, David W. Kuneman, Charles A. McWherter, Dutt V. Vinjamoori, Daniel P. Getman, Jeffrey I. Gordon, James A. Sikorski	1997	57
2	Design and Syntheses of Potent and Selective Dipeptide Inhibitors of Candida albicans Myristoyl-CoA:Protein N-Myristoyltransferase Journal of Medicinal Chemistry ·Balekudru Devadas, Mark E. Zupec, Sandra K. Freeman, David Brown, Srinivasan Nagarajan, James A. Sikorski, Charles A. McWherter, Daniel P. Getman, Jeffrey I. Gordon	1995	53
3	Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: Protein N-myristoyltransferase: A new approach to antifungal therapy Biopolymers ·James A. Sikorski, Balekudru Devadas, Mark E. Zupec, Sandra K. Freeman, David Brown, Hwang‐Fun Lu, Srinivasan Nagarajan, Pramod P. Mehta, Arlene C. Wade, Nandini S. Kishore, Martin L. Bryant, Daniel P. Getman, Charles A. McWherter, Jeffrey I. Gordon	1997	46
4	Conformationally Constrained [p-(ω-Aminoalkyl)phenacetyl]-l-seryl-l-lysyl Dipeptide Amides as Potent Peptidomimetic Inhibitors of Candida albicans and Human Myristoyl-CoA:Protein N-Myristoyl Transferase Journal of Medicinal Chemistry ·Srinivasan Nagarajan, Balekudru Devadas, Mark E. Zupec, Sandra K. Freeman, David Brown, Hwang‐Fun Lu, Pramod P. Mehta, Nandini S. Kishore, Charles A. McWherter, Daniel P. Getman, Jeffrey I. Gordon, James A. Sikorski	1997	40
5	In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent Thrombosis Research ·Nancy S. Nicholson, Susan G. Panzer‐Knodle, Anita K. Salyers, B. B. Taite, Lucy W. King, Masateru Miyano, Richard J. Gorczynski, Mark Williams, Mark E. Zupec, F. S. TJOENG, S P Adams, Larry P. Feigen	1991	38
6	Substituted 2-Iminopiperidines as Inhibitors of Human Nitric Oxide Synthase Isoforms Journal of Medicinal Chemistry ·R. Keith Webber, Suzanne Metz, William M. Moore, Jane R. Connor, Mark G. Currie, Kam F. Fok, Timothy J. Hagen, Donald W. Hansen, Gina Jerome, Pamela T. Manning, Barnett S. Pitzele, Mihaly V. Toth, Mahima Trivedi, Mark E. Zupec, F. S. TJOENG	1998	38
7	N-Myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA:protein N-myristoyltransferase Microbiology ·Jennifer K. Lodge, Emily Jackson-Machelski, Balekudru Devadas, Mark E. Zupec, Daniel P. Getman, Nandini S. Kishore, Sandra K. Freeman, Charles A. McWherter, James A. Sikorski, Jeffrey I. Gordon	1997	37
8	Substrate specificity of recombinant human renal renin: effect of histidine in the P2 subsite of pH dependence Biochemistry ·David W. Green, Serdar Aykent, James K. Gierse, Mark E. Zupec	1990	33
9	Multiple peptide synthesis using a single support (MPS3) International journal of peptide & protein research ·Foe S. Tjoeng, D S Towery, J. W. Bulock, Deborah E. Whipple, Kam F. Fok, Mark Williams, Mark E. Zupec, Steven P. Adams	1990	31
10	A novel series of orally active antiplatelet agents Bioorganic & Medicinal Chemistry ·Jeffery A. Zablocki, Foe S. Tjoeng, Philippe R. Bovy, Masateru Miyano, Robert B. Garland, Kenneth Williams, Lori A. Schretzman, Mark E. Zupec, Joseph G. Rico, R. J. Lindmark, Mihaly V. Toth, D. E. McMackins, Steven P. Adams, Susan G. Panzer‐Knodle, Nancy S. Nicholson, Beatrice B. Taite, Anita K. Salyers, Lucy W. King, James G. Campion, Larry P. Feigen	1995	30
11	Scanning Alanine Mutagenesis and De-peptidization of a Candida albicans Myristoyl-CoA:ProteinN-Myristoyltransferase Octapeptide Substrate Reveals Three Elements Critical for Molecular Recognition Journal of Biological Chemistry ·Charles A. McWherter, Warren J. Rocque, Mark E. Zupec, Sandra K. Freeman, David Brown, Balekudru Devadas, Daniel P. Getman, James A. Sikorski, Jeffrey I. Gordon	1997	29
12	Differential structure-activity relationships of atrial peptides as natriuretics and renal vasodilators in the dog Biochemical and Biophysical Research Communications ·Nobuo Katsube, K. Wakitani, Kam F. Fok, F. S. TJOENG, Mark E. Zupec, Shad R. Eubanks, S P Adams, Philip Needleman	1985	25
13	Isolation of Genomic Sequence Encoding a Biologically Active Bovine TGF- α Protein Growth Factors ·Linda L. Zurfluft, Suzanne L. Boltent, John C. Byatt, Michael McGrath, Jacob S. Tou, Mark E. Zupec, Gwen G. Krivi	1990	23
14	Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749). Journal of Pharmacology and Experimental Therapeutics ·Nancy S. Nicholson, Susan G. Panzer‐Knodle, Anita K. Salyers, B. B. Taite, Lucy W. King, Masanori MIYANO, Richard J. Gorczynski, Mark Williams, Mark E. Zupec, F. S. TJOENG	1990	17
15	Chemical synthesis of bovine transforming growth factor-α: Synthesis, characterization and biological activity Biochemical and Biophysical Research Communications ·Jacob S. Tou, Mike F. McGrath, Mark E. Zupec, John C. Byatt, Bernie N. Violand, Larry A. Kaempfe, B. D. Vineyard	1990	16
16	Phosphorylation of high‐ and low‐molecular‐mass atrial natriuretic peptide analogs by cyclic AMP‐dependent protein kinase FEBS Letters ·Gillian M. Olins, Pramod P. Mehta, Delores J. Blehm, Dennis R. Patton, Mark E. Zupec, Deborah E. Whipple, Foe S. Tjoeng, Steven P. Adams, Peter O. Olins, James K. Gierse	1987	13
17	Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents Bioorganic & Medicinal Chemistry ·Philippe R. Bovy, F. S. TJOENG, J. G. RICO, Thomas E. Rogers, R. J. Lindmark, Jeffery A. Zablocki, Robert B. Garland, D. E. McMackins, Henry E. Dayringer, Máté Tóth, Mark E. Zupec, Shashidhar N. Rao, Susan G. Panzer‐Knodle, Nancy S. Nicholson, Anita K. Salyers, B. B. Taite, M. Hérin, Masateru Miyano, Larry P. Feigen, S P Adams	1994	10
18	Replacements for lysine in l-seryl-l-lysyl dipeptide amide inhibitors of candida albicans myristoyl-CoA:protein N-myristoyltransferase Bioorganic & Medicinal Chemistry Letters ·David Brown, Balekudru Devadas, Hwang‐Fun Lu, Srinivasan Nagarajan, Mark E. Zupec, Sandra K. Freeman, Charles A. McWherter, Daniel P. Getman, James A. Sikorski	1997	10

About Mark E. Zupec

Mark E. Zupec is a scholar working on Immunology and Allergy, Hematology, Oncology, Molecular Biology and Microbiology, having authored 18 papers that have together received 546 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (4 papers), Carbohydrate Chemistry and Synthesis (4 papers), Receptor Mechanisms and Signaling (3 papers), Platelet Disorders and Treatments (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Neuropeptides and Animal Physiology (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Molecular Biology (326 citations), Immunology and Allergy (26 citations), Organic Chemistry (115 citations), Toxicology (13 citations) and Hematology (38 citations). Mark E. Zupec has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include James A. Sikorski, Daniel P. Getman, Balekudru Devadas, Sandra K. Freeman, Charles A. McWherter, Jeffrey I. Gordon, Srinivasan Nagarajan, David Brown, Nandini S. Kishore and F. S. TJOENG. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Biochemical and Biophysical Research Communications, Growth Factors and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact